Search results for "antiviral agent"

showing 10 items of 505 documents

Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling…

2017

Background Hepatitis C virus (HCV) is a leading cause of liver-related morbidity and mortality worldwide. In the European Union (EU), treatment and cure of HCV with direct-acting antiviral therapies began in 2014. WHO targets are to achieve a 65% reduction in liver-related deaths, a 90% reduction of new viral hepatitis infections, and 90% of patients with viral hepatitis infections being diagnosed by 2030. This study assessed the prevalence of HCV in the EU and the level of intervention required to achieve WHO targets for HCV elimination. Methods We populated country Markov models for the 28 EU countries through a literature search of PubMed and Embase between Jan 1, 2000, and March 31, 201…

Pediatricsddc:616.07medicine.disease_cause0302 clinical medicineCost of IllnessEpidemiologyPrevalenceEPIDEMIOLOGY030212 general & internal medicineSettore SECS-P/01 - Economia PoliticaCIRRHOSISmedia_commonddc:616Antiviral Agents/therapeutic useeducation.field_of_studyINJECT DRUGSGastroenterologyHCV INFECTIONvirus diseasesHepatitis CEmigration and ImmigrationDISEASE BURDENHepatitis CMarkov ChainsEmigration and Immigration/statistics & numerical data030211 gastroenterology & hepatologyViral hepatitisModelling ; Eradication ; European Union ; Hepatitis C ; prevalenceCOUNTRIESmedicine.medical_specialtyHepatitis C virusPopulationUNITED-STATESWorld Health OrganizationAntiviral Agents03 medical and health sciencesSDG 3 - Good Health and Well-beingPEOPLEInternal medicineIntervention (counseling)medicineJournal Articlemedia_common.cataloged_instanceHumansEuropean UnionViremiaEuropean unionDisease EradicationeducationHepatitis C/diagnosis/drug therapy/epidemiology/prevention & controlHepatologybusiness.industryViremia/diagnosis/drug therapy/epidemiology/prevention & controlHepatologymedicine.diseaseVirologyPREVENTIONdigestive system diseasesHuman medicineVIRAL-HEPATITISbusinessLancet Gastroenterology & Hepatology
researchProduct

Optimizing diagnostic algorithms to advance Hepatitis C elimination in Italy: A cost effectiveness evaluation

2021

Objectives: Optimized diagnostic algorithms to detect active infections are crucial to achieving HCV elimination. We evaluated the cost effectiveness and sustainability of different algorithms for HCV active infection diagnosis, in a context of a high endemic country for HCV infection. Methods: A Markov disease progression model, simulating six diagnostic algorithms in the birth cohort 1969‐1989 over a 10‐year horizon from a healthcare perspective was used. Conventionally diagnosis of active HCV infection is through detection of antibodies (HCV‐Ab) detection followed by HCV‐RNA or HCV core antigen (HCV‐Ag) confirmatory testing either on a second sample or by same sample reflex testing. The …

Pediatricsmedicine.medical_specialtyCost effectivenessCost-Benefit Analysiscost-effectiveneContext (language use)HepacivirusAntiviral AgentsLiver diseaseMedicineHumansbusinesshealth care economics and organizationsHepatologybusiness.industryscreeningDisease progressionHCV chronic infectionvirus diseasesDiagnostic algorithmshealthHepatitis CHepatitis C Chronicmedicine.diseaseHepatitis CHcv eliminationdigestive system diseasesWHO targetHcv core antigenbusinessAlgorithms
researchProduct

Semisynthesis of the Antiviral Abietane Diterpenoid Jiadifenoic Acid C from Callitrisic Acid (4-Epidehydroabietic Acid) Isolated from Sandarac Resin

2014

The semisynthesis of the antiviral abietane diterpenoid (+)-jiadifenoic acid C starting from the available methyl ester of callitrisic acid (4-epidehydroabietic acid) isolated from sandarac resin is reported. A protocol for the isolation of methyl callitrisate (methyl 4-epidehydroabietate) in gram quantities from sandarac resin is also described. Allylic C-17 oxygenation was introduced by regioselective dehydrogenation of the isopropyl group of methyl callitrisate with DDQ followed by selenium-catalyzed allylic oxidation. Ester hydrolysis afforded (+)-jiadifenoic acid C in 22% overall yield from methyl callitrisate. This semisynthetic route provides a convenient source of this anti-Coxsacki…

PharmacologyAllylic rearrangementNatural productMolecular StructureChemistryOrganic ChemistrySandaracPharmaceutical ScienceRegioselectivityAntiviral AgentsSemisynthesisTerpenoidEnterovirus B HumanAnalytical Chemistrychemistry.chemical_compoundComplementary and alternative medicineAbietanesDrug DiscoveryMolecular MedicineOrganic chemistryNuclear Magnetic Resonance BiomolecularOxidation-ReductionResins PlantIsopropylAbietaneJournal of Natural Products
researchProduct

Taking Advantage of Viral Immune Evasion: Virus-Derived Proteins Represent Novel Biopharmaceuticals

2006

In healthy individuals, natural and adaptive immune responses are able to control virus entry into the host. In particular, CD8(+)-mediated cytotoxicity, sustained by the intervention of CD4+ cells, represents the major key event leading to virus eradication. On the other hand, viruses are able to evade from host immune response via several mechanisms, and special emphasis will be placed on hepatitis C virus and chronic Epstein-Barr infections also in view of personal data. Virokines, viroreceptors, and serpins greatly contribute to viral immune escape, and, among virokines, interleukin (IL)-10 has been object of intensive studies. Finally, all these products have been used as biopharmaceut…

PharmacologyHepatitis C virusOrganic ChemistryInterleukinVirus Physiological PhenomenaBiologymedicine.disease_causeAntiviral AgentsBiochemistryVirologyVirusViral ProteinsImmune systemViral entryVirusesDrug DiscoveryImmunologyAntigenic variationmedicineHumansMolecular MedicineCD8Virus Physiological PhenomenaCurrent Medicinal Chemistry
researchProduct

Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors

2023

Viruses have been recognized as the etiological agents responsible for many pathological conditions ranging from asymptomatic infections to serious diseases, even leading to death. For this reason, many efforts have been made to identify selective viral targets with the aim of developing efficient therapeutic strategies, devoid of drug-resistance issues. Considering their crucial role in the viral life cycle, polymerases are very attractive targets. Among the classes of compounds explored as viral polymerases inhibitors, here we present an overview of non-nucleoside triazole-based compounds identified in the last fifteen years. Furthermore, the structure-activity relationships (SAR) of the …

PharmacologyOrganic ChemistryDrug Discovery123-TriazolesNon-nucleosides antiviral agentsViral polymerasesGeneral MedicineAntiviral therapy124-TriazolesEuropean Journal of Medicinal Chemistry
researchProduct

Tannins from Hamamelis virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papill…

2014

Antiviral activity has been demonstrated for different tannin-rich plant extracts. Since tannins of different classes and molecular weights are often found together in plant extracts and may differ in their antiviral activity, we have compared the effect against influenza A virus (IAV) of Hamamelis virginiana L. bark extract, fractions enriched in tannins of different molecular weights and individual tannins of defined structures, including pseudotannins. We demonstrate antiviral activity of the bark extract against different IAV strains, including the recently emerged H7N9, and show for the first time that a tannin-rich extract inhibits human papillomavirus (HPV) type 16 infection. As the …

PhytochemistryViral DiseasesPhytopharmacologylcsh:MedicineEpigallocatechin gallateMadin Darby Canine Kidney Cellschemistry.chemical_compoundMolecular Cell BiologyDrug DiscoveryTanninGallic acidlcsh:Sciencechemistry.chemical_classificationHuman papillomavirus 16MultidisciplinarybiologyChemistryInfectious DiseasesBiochemistryProanthocyanidinInfluenza A virusvisual_artPlant Barkvisual_art.visual_art_mediumMedicineBarkResearch Articlemedicine.drugDrugs and DevicesHuman Papillomavirus InfectionDrug Research and DevelopmentSexually Transmitted DiseasesHamamelisAntiviral AgentsDogsComplementary and Alternative MedicineInfluenza HumanTannic acidmedicineAnimalsHumansBiologyPlant Extractslcsh:RPapillomavirus InfectionsHamamelis virginianaInfluenzachemistrybiology.proteinlcsh:QTanninsNeuraminidasePLoS ONE
researchProduct

Hepatitis C Virus NS3/4A Protease Inhibitors.

2008

Chronic hepatitis C virus infection is a global problem worldwide due to the lack of an effective therapy (the current standard of care treatment is effective in about 40-50% of the cases), and the difficulties in developing a protective vaccine. Chronic infection progresses to end-stage liver disease and liver failure in a considerable number of infected individuals. Once liver function is compromised, the only reliable therapeutic intervention is liver transplantation. Unfortunately, re-infection of the graft is unavoidable, and a new chronic hepatitis is early established in transplant recipients, that can result in graft loss. Thus, there is an urgent need for new, specifically targeted…

ProlineHepatitis B virus DNA polymerasevirusesmedicine.medical_treatmentHepacivirusLiver transplantationViral Nonstructural ProteinsAntiviral AgentsLiver diseaseDrug DiscoveryDrug Resistance ViralmedicinePharmacology (medical)NS3Proteasebusiness.industryvirus diseasesGeneral Medicinemedicine.diseasedigestive system diseasesNS2-3 proteaseChronic infectionInfectious DiseasesImmunologyLiver functionbusinessOligopeptidesRecent patents on anti-infective drug discovery
researchProduct

Biochemistry and medicinal chemistry of the dengue virus protease.

2014

ProteaseChemistryProtein Conformationmedicine.medical_treatmentGeneral ChemistryDengue virusDengue Virusmedicine.disease_causeMedicinal chemistryAntiviral AgentsSubstrate SpecificityBiochemistrymedicineSubstrate specificityProtease InhibitorsPeptide HydrolasesChemical reviews
researchProduct

Enteroviruses and coronaviruses: similarities and therapeutic targets

2021

ABSTRACT Introduction: Enteroviruses are common viruses causing a huge number of acute and chronic infections and producing towering economic costs. Similarly, coronaviruses cause seasonal mild infections, epidemics, and even pandemics and can lead to severe respiratory symptoms. It is important to develop broadly acting antiviral molecules to efficiently tackle the infections caused by thes. Areas covered: This review illuminates the differences and similarities between enteroviruses and coronaviruses and examines the most appealing therapeutic targets to combat both virus groups. Publications of both virus groups and deposited structures discovered through PubMed to March 2021 for viral p…

ProteasesPolyproteinsvirusesmedicine.medical_treatmentClinical BiochemistrycoronavirusReviewSARS-COV-2Biologymedicine.disease_causeAntiviral Agents3C proteaseVirusSubstrate Specificity03 medical and health sciencesDrug DiscoveryPandemicmedicineAnimalsHumansVirus classificationEnterovirus030304 developmental biologyCoronavirusPharmacology0303 health sciencesProtease030306 microbiologyCOVID-19Virology3. Good healthCysteine Endopeptidasesmain proteaseMolecular MedicineEnterovirusResearch ArticleExpert Opinion on Therapeutic Targets
researchProduct

Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases

2019

The NS2B/NS3 serine proteases of the Zika and Dengue flaviviruses are attractive targets for the development of antiviral drugs. We report the synthesis and evaluation of a new, proline-based compound class that displays allosteric inhibition of both proteases. The structural features relevant for protease binding and inhibition were determined to establish them as new lead compounds for flaviviral inhibitors. Based on our structure-activity relationship studies, the molecules were further optimized, leading to inhibitors with submicromolar IC50 values and improved lipophilic ligand efficiency. The allosteric binding site in the proteases was probed using mutagenesis and covalent modificati…

ProteasesProlineProtein ConformationAllosteric regulationViral Nonstructural ProteinsDengue virusmedicine.disease_causeAntiviral Agents01 natural sciencesDengueSerineStructure-Activity RelationshipViral Proteins03 medical and health sciencesAllosteric RegulationCatalytic DomainDrug DiscoverymedicineHumansStructure–activity relationshipProtease Inhibitors030304 developmental biology0303 health sciencesNS3Ligand efficiencyZika Virus InfectionChemistryProtease bindingSerine EndopeptidasesZika VirusDengue Virus0104 chemical sciencesMolecular Docking Simulation010404 medicinal & biomolecular chemistryBiochemistryA549 CellsMolecular MedicineAllosteric SitePeptide HydrolasesProtein BindingJournal of Medicinal Chemistry
researchProduct